Evidence map›Paper›PMID 25706389›Full record

ArticlePloS one2015

Granulocyte-macrophage colony stimulatory factor enhances the pro-inflammatory response of interferon-γ-treated macrophages to Pseudomonas aeruginosa infection.

Sonali Singh, Helen Barr, Yi-Chia Liu, Adrian Robins, Stephan Heeb, Paul Williams, Andrew Fogarty, Miguel Cámara, Luisa Martínez-Pomares

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Frontiers in immunology · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. UnderstandingCells · 2020
    Review
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Sonali SinghSchool of Life Sciences, University of Nottingham, Nottingham, NG7 2RD, United Kingdom.
Helen BarrSchool of Medicine, University of Nottingham, Nottingham, NG7 2RD, United Kingdom.
Yi-Chia LiuSchool of Life Sciences, University of Nottingham, Nottingham, NG7 2RD, United Kingdom.
Adrian RobinsSchool of Life Sciences, University of Nottingham, Nottingham, NG7 2RD, United Kingdom.
Stephan HeebSchool of Life Sciences, University of Nottingham, Nottingham, NG7 2RD, United Kingdom.
Paul WilliamsSchool of Life Sciences, University of Nottingham, Nottingham, NG7 2RD, United Kingdom.
Andrew FogartySchool of Community Health Sciences, University of Nottingham, Nottingham, NG7 2RD, United Kingdom.
Miguel CámaraSchool of Life Sciences, University of Nottingham, Nottingham, NG7 2RD, United Kingdom.
Luisa Martínez-PomaresSchool of Life Sciences, University of Nottingham, Nottingham, NG7 2RD, United Kingdom.
University of Nottingham · GB

Funding

Medical Research Council G0801558
6 · The paper itself

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen that can cause severe infections at compromised epithelial surfaces, such those found in burns, wounds, and in lungs damaged by mechanical ventilation or recurrent infections, particularly in cystic fibrosis (CF) patients. CF patients have been proposed to have a Th2 and Th17-biased immune response suggesting that the lack of Th1 and/or over exuberant Th17 responses could contribute to the establishment of chronic P. aeruginosa infection and deterioration of lung function. Accordingly, we have observed that interferon (IFN)-γ production by peripheral blood mononuclear cells from CF patients positively correlated with lung function, particularly in patients chronically infected with P. aeruginosa. In contrast, IL-17A levels tended to correlate negatively with lung function with this trend becoming significant in patients chronically infected with P. aeruginosa. These results are in agreement with IFN-γ and IL-17A playing protective and detrimental roles, respectively, in CF. In order to explore the protective effect of IFN-γ in CF, the effect of IFN-γ alone or in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), on the ability of human macrophages to control P. aeruginosa growth, resist the cytotoxicity induced by this bacterium or promote inflammation was investigated. Treatment of macrophages with IFN-γ, in the presence and absence of GM-CSF, failed to alter bacterial growth or macrophage survival upon P. aeruginosa infection, but changed the inflammatory potential of macrophages. IFN-γ caused up-regulation of monocyte chemoattractant protein-1 (MCP-1) and TNF-α and down-regulation of IL-10 expression by infected macrophages. GM-CSF in combination with IFN-γ promoted IL-6 production and further reduction of IL-10 synthesis. Comparison of TNF-α vs. IL-10 and IL-6 vs. IL-10 ratios revealed the following hierarchy in regard to the pro-inflammatory potential of human macrophages infected with P. aeruginosa: untreated < treated with GM-CSF < treated with IFN-γ < treated with GM-CSF and IFN-γ.

Indexed as

AdolescentAdultCystic FibrosisCytokinesFemaleGranulocyte-Macrophage Colony-Stimulating FactorHumansInflammationInterferon-gammaMacrophagesMalePseudomonas aeruginosaPseudomonas InfectionsYoung AdultCytokinesGranulocyte-Macrophage Colony-Stimulating FactorInterferon-gamma

Identifiers

PMID25706389
PMCPMC4338139
OpenAlexW2079885232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.